CACNG4
Voltage-dependent calcium channel gamma-4 subunit
Also known as: CCG4_HUMAN, MGC11138, MGC24983
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBN1
- Gene
- CACNG4
- Ensembl
- ENSG00000075461
- Chromosome
- 17
- Canonical length
- 327 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a type I transmembrane AMPA receptor regulatory protein (TARP). TARPs regulate both trafficking and channel gating of the AMPA receptors. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family and is located in a cluster with two family members, a type II TARP and a calcium channel gamma subunit. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q9UBN1|CACNG4
1 MVRCDRGLQM LLTTAGAFAA FSLMAIAIGT DYWLYSSAHI CNGTNLTMDD GPPPRRARGD
61 LTHSGLWRVC CIEGIYKGHC FRINHFPEDN DYDHDSSEYL LRIVRASSVF PILSTILLLL
121 GGLCIGAGRI YSRKNNIVLS AGILFVAAGL SNIIGIIVYI SSNTGDPSDK RDEDKKNHYN
181 YGWSFYFGAL SFIVAETVGV LAVNIYIEKN KELRFKTKRE FLKASSSSPY ARMPSYRYRR
241 RRSRSSSRST EASPSRDVSP MGLKITGAIP MGELSMYTLS REPLKVTTAA SYSPDQEASF
301 LQVHDFFQQD LKEGFHVSML NRRTTPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CACNG4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 58 nTPM
- amygdala: 35 nTPM
- hypothalamus: 29 nTPM
- cerebral cortex: 24 nTPM
- hippocampal formation: 24 nTPM
- midbrain: 17 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 284 nCPM
- alveolar cells type 1: 104 nCPM
- bergmann glia: 89 nCPM
- brain inhibitory neurons: 74 nCPM
- adrenal medulla cells: 43 nCPM
- respiratory ciliated cells: 39 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 68 nTPM
- thalamus: 58 nTPM
- amygdala: 51 nTPM
- hypothalamus: 33 nTPM
- midbrain: 31 nTPM
- cerebral cortex: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.82
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of synaptic transmission, glutamatergic
- postsynaptic neurotransmitter receptor diffusion trapping
- regulation of AMPA receptor activity
- response to cocaine
- transmission of nerve impulse
Molecular functions
- calcium channel regulator activity
- channel regulator activity
- ionotropic glutamate receptor binding
- voltage-gated calcium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PMP-22/EMP/MP20/Claudin
- Voltage-dependent calcium channel, gamma subunit
- Voltage-dependent calcium channel gamma subunit
- PMP-22/EMP/MP20/Claudin family
- Voltage-dependent calcium channel, gamma-4 subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CACNG4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CACNG4 as an antibody target. Whether an autoantibody or antibody against CACNG4 could matter depends on whether native CACNG4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CACNG4 is annotated at the cell surface, where native CACNG4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CACNG4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...